HLB Therapeutics Co.,Ltd.
115450
Kedudukan dalam Saham
#18716
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Harga Saham
$1.88
Modal Pasaran
$177.26M
Perubahan (1 hari)
-0.73%
Perubahan (1 tahun)
-6.17%
Negara
KR
Perdagangan HLB Therapeutics Co.,Ltd. (115450)
Kategori
Healthcare
Modal pasaran bagi HLB Therapeutics Co.,Ltd.(115450)
Modal Pasaran: $177.26M
Sehingga October 2026, HLB Therapeutics Co.,Ltd. mempunyai modal pasaran sebanyak $177.26M. Ini menjadikan HLB Therapeutics Co.,Ltd. syarikat ke-18716th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran HLB Therapeutics Co.,Ltd. dari 2010 hingga 2026
115450 berbanding dengan 5 teratas yang paling popular stocks
